专业监测看板

Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands

药物 / 成分：Tirbanibulin

登记的停止原因（原文）：lack of ressources

The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes

药物 / 成分：Lipoic acid

JDQ443 for KRAS G12C NSCLC Brain Metastases

药物 / 成分：JDQ443

登记的停止原因（原文）：Novartis discontinued develpment of JDQ443

12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi

药物 / 成分：NFX-179 Gel 1.50%

登记的停止原因（原文）：Sponsored declined to proceed

Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System

药物 / 成分：Gardasil、Gardasil、Gardasil、PharmaJet Stratis® Needle-Free Injection System

登记的停止原因（原文）：Change in landscape of HPV treatment

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

药物 / 成分：Peginterferon Lambda

登记的停止原因（原文）：Study closure based on decision of the PI

Low-dose IL-2 in Established T1D - The "PROREG" Study

药物 / 成分：ILT-101 (Aldesleukin; IL-2)、Treatment-Placebo Arm、Placebo Arm

登记的停止原因（原文）：Funding withdrawal and COVID-19 environment.

Buprenorphine Induction for Fentanyl Dependent Opioid Users

药物 / 成分：Buprenorphine/naloxone

登记的停止原因（原文）：Unable to enroll--patients uninterested in trying buprenorphine.

Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder

药物 / 成分：Nabilone、Placebo

登记的停止原因（原文）：The Principal Investigator is no longer at the Institution and a request for early termination of the grant supporting the study was submitted to NIH.

Effects of Stulln and Accommodative Training

药物 / 成分：Stulln Eyedrops、Thera Tears

登记的停止原因（原文）：unable to attend the drug for study

R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma

药物 / 成分：R-DHAP、Pola-R-DHAP

登记的停止原因（原文）：Sponsor decision

Prophylactic Lisinopril to Prevent Anthracycline Cardiomyopathy.

药物 / 成分：Lisinopril、Placebo Oral Tablet

登记的停止原因（原文）：PI Andrew Hinojos Left Institution (Genesys) prior to Ascension Acquiring record

Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction

药物 / 成分：Adenosine

登记的停止原因（原文）：Never started

Oral Iloprost for the Prevention of Lung Cancer In Former Smokers

药物 / 成分：Biospecimen Collection、Bronchial Brush Biopsy、Bronchoscopy、Iloprost

登记的停止原因（原文）：Agent is not available

Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)

药物 / 成分：Biospecimen Collection、Bone Marrow Aspiration、Bone Marrow Biopsy、Calaspargase Pegol

登记的停止原因（原文）：Other - Protocol moved to Disapproved

Empagliflozin Effect on Glucose Toxicity

药物 / 成分：Empagliflozin (Jardiance®)、Insulin Glargine (Lantus®)

登记的停止原因（原文）：poor recruitment

PDE5i Use in Renal Transplant Recipients

药物 / 成分：Sildenafil

登记的停止原因（原文）：iss

A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique

药物 / 成分：BOTOX Dose A、Placebo for BOTOX、BOTOX Dose B、BOTOX Dose C

登记的停止原因（原文）：Strategic considerations

A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver Disease

药物 / 成分：PRIM-DJ2727、Placebo

登记的停止原因（原文）：lack of funds

An Investigator-initiated Study to Evaluate Safety and Efficacy of ARINA-1 in People With a Tracheostomy

药物 / 成分：ARINA-1

登记的停止原因（原文）：Terminated due to enrollment challenges